StockData
CLCSOTCPharmaceutical PreparationsFiscal year ends December 31

Cell Source, Inc.

Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)

Close on Oct 19, 2026

Market cap
$21.99M
P/E (TTM)
–
Dividend yield
–

Cell Source statistics

Financials through Mar 31, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison

Valuation

MeasureCell SourceIndustry median
Market Cap$33.18M$197.05M
Enterprise Value$33.18M$106.56M

Income (trailing twelve months)

MeasureCell SourceIndustry median
Operating Income-$3.70M-$21.44M
Net Income-$4.72M-$22.46M
EBITDA-$3.70M-$16.91M
EPS (Diluted)-$0.14-$0.83

Returns

MeasureCell SourceIndustry median
Return on Assets (ROA)-1613.7%-41.0%

Balance sheet

MeasureCell SourceIndustry median
Cash & Short-Term Investments$1.24K$62.42M
Net Cash (Debt)$1.24K$15.68M
Net Cash Per Share$0.00$0.65
Equity (Book Value)-$20.14M$48.79M
Book Value Per Share-$0.30$1.36
Tangible Book Value-$20.14M$23.06M

Cash flow (trailing twelve months)

MeasureCell SourceIndustry median
Operating Cash Flow-$3.11M-$12.35M

Efficiency

MeasureCell SourceIndustry median
Profits Per Employee-$4.72M-$732.08K
Employee Count173

Dividends and yields

MeasureCell SourceIndustry median
Earnings Yield-14.2%-21.2%

Shares

MeasureCell SourceIndustry median
Shares Outstanding67,945,90059,128,900
Shares Change (QoQ)0.00%0.54%
Float67,945,90048,744,500
Shares Held by Insiders0.00%11.8%

Scores

MeasureCell SourceIndustry median
Altman Z-Score-268.950.10

Calculated by StockData from Cell Source's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.